A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer

被引:193
|
作者
Silvestri, Gerard A. [1 ]
Vachani, Anil [2 ]
Whitney, Duncan [3 ,5 ]
Elashoff, Michael [6 ]
Smith, Kate Porta [3 ,5 ]
Ferguson, J. Scott [7 ]
Parsons, Ed [3 ]
Mitra, Nandita [2 ]
Brody, Jerome [4 ]
Lenburg, Marc E. [4 ]
Spira, Avrum [4 ]
机构
[1] Med Univ S Carolina, Charleston, SC USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Allegro Diagnost, Maynard, MA USA
[4] Boston Univ, Sch Med, Boston, MA 02118 USA
[5] Veracyte, San Francisco, CA USA
[6] Elashoff Consulting, Redwood City, CA USA
[7] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 373卷 / 03期
基金
美国国家卫生研究院;
关键词
AMERICAN-COLLEGE; GENE-EXPRESSION; NODULES; MANAGEMENT; PREDICTION; GUIDELINES; BIOPSY;
D O I
10.1056/NEJMoa1504601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Bronchoscopy is frequently nondiagnostic in patients with pulmonary lesions suspected to be lung cancer. This often results in additional invasive testing, although many lesions are benign. We sought to validate a bronchial-airway gene-expression classifier that could improve the diagnostic performance of bronchoscopy. METHODS Current or former smokers undergoing bronchoscopy for suspected lung cancer were enrolled at 28 centers in two multicenter prospective studies (AEGIS-1 and AEGIS-2). A gene-expression classifier was measured in epithelial cells collected from the normal-appearing mainstem bronchus to assess the probability of lung cancer. RESULTS A total of 639 patients in AEGIS-1 (298 patients) and AEGIS-2 (341 patients) met the criteria for inclusion. A total of 43% of bronchoscopic examinations were nondiagnostic for lung cancer, and invasive procedures were performed after bronchoscopy in 35% of patients with benign lesions. In AEGIS-1, the classifier had an area under the receiver-operating-characteristic curve (AUC) of 0.78 (95% confidence interval [CI], 0.73 to 0.83), a sensitivity of 88% (95% CI, 83 to 92), and a specificity of 47% (95% CI, 37 to 58). In AEGIS-2, the classifier had an AUC of 0.74 (95% CI, 0.68 to 0.80), a sensitivity of 89% (95% CI, 84 to 92), and a specificity of 47% (95% CI, 36 to 59). The combination of the classifier plus bronchoscopy had a sensitivity of 96% (95% CI, 93 to 98) in AEGIS-1 and 98% (95% CI, 96 to 99) in AEGIS-2, independent of lesion size and location. In 101 patients with an intermediate pretest probability of cancer, the negative predictive value of the classifier was 91% (95% CI, 75 to 98) among patients with a nondiagnostic bronchoscopic examination. CONCLUSIONS The gene-expression classifier improved the diagnostic performance of bronchoscopy for the detection of lung cancer. In intermediate-risk patients with a nondiagnostic bronchoscopic examination, a negative classifier score provides support for a more conservative diagnostic approach.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF A BRONCHIAL GENOMIC CLASSIFIER FOR THE DIAGNOSTIC EVALUATION OF LUNG CANCER
    Feller-Kopman, D.
    Liu, S.
    Geisler, B. P.
    DeCamp, M. M.
    Pietzsch, J. B.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A247 - A247
  • [2] Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
    Feller-Kopman, David
    Liu, Shan
    Geisler, Benjamin R.
    DeCamp, Malcolm M.
    Pietzsch, Jan B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : 1223 - 1232
  • [3] Impact Of A Bronchial Genomic Classifier On Clinical Decision Making In Patients Undergoing Diagnostic Evaluation For Lung Cancer
    Ferguson, J. S.
    Van Wert, R.
    Choi, Y.
    Rosenbluth, M.
    Huang, J.
    Spira, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer
    Ferguson, J. Scott
    Van Wert, Ryan
    Choi, Yoonha
    Rosenbluth, Michael J.
    Smith, Kate Porta
    Huang, Jing
    Spira, Avrum
    [J]. BMC PULMONARY MEDICINE, 2016, 16
  • [5] Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer
    J. Scott Ferguson
    Ryan Van Wert
    Yoonha Choi
    Michael J. Rosenbluth
    Kate Porta Smith
    Jing Huang
    Avrum Spira
    [J]. BMC Pulmonary Medicine, 16
  • [6] Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy
    Whitney, Duncan H.
    Elashoff, Michael R.
    Porta-Smith, Kate
    Gower, Adam C.
    Vachani, Anil
    Ferguson, J. Scott
    Silvestri, Gerard A.
    Brody, Jerome S.
    Lenburg, Marc E.
    Spira, Avrum
    [J]. BMC MEDICAL GENOMICS, 2015, 8
  • [7] Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy
    Duncan H Whitney
    Michael R Elashoff
    Kate Porta-Smith
    Adam C Gower
    Anil Vachani
    J Scott Ferguson
    Gerard A Silvestri
    Jerome S Brody
    Marc E Lenburg
    Avrum Spira
    [J]. BMC Medical Genomics, 8
  • [8] Cost-Effectiveness Of The Percepta Bronchial Genomic Classifier For The Diagnostic Evaluation Of Lung Cancer: An Analytical Framework Based On The Aegis Studies
    Feller-Kopman, D. J.
    Liu, S.
    Garner, A. M.
    Decamp, M.
    Pietzsch, J. B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Prospective Validation of a Bronchial Genomic Classifier for Lung Cancer in Patients Undergoing Diagnostic Bronchoscopy: The AEGIS Trials
    Vachani, Anil
    Silvestri, Gerard
    Whitney, Duncan
    Ferguson, J.
    Porta, Kate
    Parsons, Edward
    Brody, Jerome
    Lenburg, Marc
    Spira, Avrum
    [J]. CHEST, 2015, 148 (04)
  • [10] A Bronchial Genomic Classifier Measured in Airway Epithelial Cells Improves Diagnostic Sensitivity of Bronchoscopy for Lung Cancer
    Vachani, Anil
    Whitney, Duncan
    Gower, Adam C.
    Porta-Smith, Kate
    Ferguson, J. S.
    Brody, Jerome
    Silvestri, Gerard
    Lenburg, Marc
    Spira, Avrum
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S252 - S252